Pharmsynthez (MOEX:LIFE)
Russia · Delayed Price · Currency is RUB 4.505
+0.415 (10.15%)
At close: Jul 8, 2022
Pharmsynthez Cash Flow Statement
Financials in millions RUB. Fiscal year is January - December.
Millions RUB. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -253.91 | 254.41 | -207.49 | -697.55 | -524.81 |
Depreciation & Amortization | 32.85 | 36.77 | 27.51 | 31.96 | 44.4 |
Loss (Gain) From Sale of Assets | - | - | - | 1.21 | -6.01 |
Loss (Gain) From Sale of Investments | - | - | 19.49 | 388.99 | 196.11 |
Loss (Gain) on Equity Investments | - | - | 14.38 | 17.04 | 56.2 |
Provision & Write-off of Bad Debts | - | - | 0.57 | 160.14 | - |
Other Operating Activities | 221.07 | -297.2 | 46.81 | -8.67 | 24.66 |
Change in Accounts Receivable | - | - | 9.86 | 15.76 | 74.1 |
Change in Inventory | - | - | -8.96 | 9.63 | 7.69 |
Change in Accounts Payable | - | - | 107.15 | -36.82 | -105.1 |
Change in Other Net Operating Assets | - | - | -12.66 | -0.8 | - |
Operating Cash Flow | 0.01 | -6.02 | -3.35 | -62.7 | -232.76 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Capital Expenditures | -12.26 | -31.36 | -3.47 | -0.28 | -9.68 |
Sale of Property, Plant & Equipment | - | 10.13 | - | - | - |
Investment in Securities | - | -0.5 | - | - | - |
Other Investing Activities | - | 15.22 | - | - | - |
Investing Cash Flow | -12.26 | -6.52 | -4.47 | -1.9 | -9.68 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Long-Term Debt Issued | 8.68 | 0.17 | 7.85 | 89.44 | 107.71 |
Total Debt Issued | 8.68 | 0.17 | 7.85 | 89.44 | 107.71 |
Long-Term Debt Repaid | - | - | -33.56 | -21.32 | -16.09 |
Lease Payments | - | - | -6.68 | -1.31 | - |
Total Debt Repaid | - | - | -33.56 | -21.32 | -16.09 |
Net Debt Issued (Repaid) | 8.68 | 0.17 | -25.71 | 68.11 | 91.62 |
Issuance of Common Stock | - | - | 23.74 | - | 87.26 |
Financing Cash Flow | 8.68 | 0.17 | -1.97 | 68.11 | 178.88 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Foreign Exchange Rate Adjustments | 0.11 | -0.32 | 3.68 | 1.37 | 7.05 |
Miscellaneous Cash Flow Adjustments | - | - | -0 | 0 | 0 |
Net Cash Flow | -3.46 | -12.7 | -6.12 | 4.88 | -56.52 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Free Cash Flow | -12.25 | -37.39 | -6.82 | -62.97 | -242.45 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -7.86% | -15.11% | -1.80% | -14.37% | -65.23% |
Free Cash Flow Per Share | -0.03 | -0.09 | -0.02 | -0.21 | -0.81 |
Levered Free Cash Flow | 42.7 | - | 20.98 | 87.89 | -339.32 |
Unlevered Free Cash Flow | 60.41 | - | 46.81 | 110.63 | -320.85 |
Free Cash Flow After Leases | -12.25 | -37.39 | -13.51 | -64.28 | -242.45 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash Interest Paid | - | - | 4.97 | 11.23 | 6.52 |
Cash Income Tax Paid | - | - | - | - | 0.11 |
Change in Working Capital | - | - | 95.39 | -12.22 | -23.31 |